Back to Trials
NCT05663203NARecruitingAccepts Healthy Volunteers

A Web-Based Dyadic Intervention for Colorectal Cancer

Emory University

Start Date

5/1/2023

Completion Date

10/1/2027

Summary

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

Detailed Description

PRIMARY OBJECTIVES: I. To develop a web-based dyadic intervention for patients with colorectal cancer receiving chemotherapy and their caregivers (CRCweb). Ia. Determine tailored contents by identifying needs and supports for a web-based dyadic intervention using interviews with patient-caregiver dyads (n=8); Ib. Develop a prototype of a web-based dyadic intervention program (CRCweb); Ic. Test the usability (e.g., design, navigation, structure, language) of CRCweb prototype using interviews with 4 dyads (in Aim Ia). II. Evaluate the feasibility and acceptability of CRCweb for patients with colorectal cancer receiving chemotherapy and their caregivers in 20 dyads in a pilot clinical trial. III. Evaluate the preliminary effects of CRCweb on the primary outcome (i.e., attrition, adherence, acceptability, fatigue, depression, sleep disturbance, pain, and cognitive dysfunction) and secondary outcomes (i.e., quality of life) for patients with colorectal cancer receiving chemotherapy and their caregivers in 20 dyads in a pilot clinical trial. OUTLINE: Patients and caregivers attend a CRCweb intervention over 8 weeks. Patients and caregivers complete interviews and surveys throughout the trial.

Eligibility Criteria

Age Range: 18 years to No maximum

INCLUSION CRITERIA Patients: * Age \>= 18 years * Diagnosed with colorectal cancer * Life expectancy \> 12 months * Receiving active chemotherapy * Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores) * Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support) * Access to the Internet * Fluent in English Caregivers: * Age \>= 18 years * Primary caregiver * Access to the Internet * Fluent in English EXCLUSION CRITERIA Patients: • Karnofsky Performance Scale \< 50 Caregivers: • Have severe diseases (e.g., cancer, heart disease)

Interventions

OTHER

Internet-Based Intervention

OTHER

Interview

OTHER

Survey Administration

OTHER

Electronic Health Record Review

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Colorectal Carcinoma

Locations

Emory University/Winship Cancer Institute

Atlanta, Georgia 30322

United States